{"DataElement":{"publicId":"2188874","version":"1","preferredName":"Overall Lesion Response Status","preferredDefinition":"information about the overall response status for target, non-target, and new lesions.","longName":"OVERAL_LES_RESP_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188872","version":"1","preferredName":"Overall Lesion Response","preferredDefinition":"Information relating to the overall lesion response.","longName":"OVERALL_LES_RESP","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206600","version":"1","preferredName":"Overall Lesion","preferredDefinition":"Including everything.:(LEE-zhun) An area of abnormal tissue change.","longName":"C25605:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FBC1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C180D-8D57-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"8/7/18 jk added irRECIST CSI.  8/30/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188873","version":"1","preferredName":"Overall Lesion Response Status","preferredDefinition":"information about the overall response status for target, non-target, and new lesions.","longName":"OVERAL_LES_RESP_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete Response","valueDescription":"Complete Response","ValueMeaning":{"publicId":"2570187","version":"1","preferredName":"Complete Response","longName":"2570187","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5B3C368-26F2-16CF-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Partial Response","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2570560","version":"1","preferredName":"Partial Response","longName":"2570560","preferredDefinition":"Partial Response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-15","changeDescription":null,"administrativeNotes":"2023.9.15 Alt VM added per ticket request CADSR0002857. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5B3C368-26F4-16CF-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Incomplete Response","valueDescription":"Incomplete Response","ValueMeaning":{"publicId":"2571999","version":"1","preferredName":"Incomplete Response","longName":"2571999","preferredDefinition":"Incomplete Response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E64C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SHIDED","dateModified":"2004-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5B3C368-26F7-16CF-E034-0003BA3F9857","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Progressive Disease","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5B3C368-26FA-16CF-E034-0003BA3F9857","beginDate":"2002-07-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Insufficient evaluation to determine response status","valueDescription":"insufficient evaluation to determine response status","ValueMeaning":{"publicId":"2568727","version":"1","preferredName":"insufficient evaluation to determine response status","longName":"2568727","preferredDefinition":"insufficient evaluation to determine response status","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D984-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-18","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5B3C368-26FC-16CF-E034-0003BA3F9857","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Stable disease","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6292BC4A-F9D3-5641-E040-BB89AD4369BB","beginDate":"2009-02-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-02-10","modifiedBy":"ONEDATA","dateModified":"2009-02-10","deletedIndicator":"No"},{"value":"Minor response","valueDescription":"minor response","ValueMeaning":{"publicId":"2568493","version":"1","preferredName":"minor response","longName":"2568493","preferredDefinition":"minor response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D89A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6292BC4A-F9E7-5641-E040-BB89AD4369BB","beginDate":"2009-02-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-02-10","modifiedBy":"ONEDATA","dateModified":"2009-02-10","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Not Evaluable","ValueMeaning":{"publicId":"2559597","version":"1","preferredName":"Not Evaluable","longName":"2559597","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5DA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B8FBAF-317A-B77B-E040-BB89AD434C12","beginDate":"2009-09-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"Progression","valueDescription":"PROGRESSION","ValueMeaning":{"publicId":"2559902","version":"1","preferredName":"PROGRESSION","longName":"2559902","preferredDefinition":"The worsening of a disease over time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B70B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CAMPBELB","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D2999F-E983-5972-E040-BB89AD430B3F","beginDate":"2012-01-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"Regression","valueDescription":"Regression","ValueMeaning":{"publicId":"2631957","version":"1","preferredName":"Regression","longName":"2631957","preferredDefinition":"A decrease in the size of a tumor or in the extent of cancer in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Regression","conceptCode":"C18243","definition":"Return to a former state; a subsidence of the symptoms of a disease process; in cancer, a decrease in the size of a tumor or in the extent of cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EDE3CEA-3A2C-2970-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-04-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D2999F-E997-5972-E040-BB89AD430B3F","beginDate":"2012-01-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"Metachronous","valueDescription":"Metachronous Malignant Neoplasm","ValueMeaning":{"publicId":"3357337","version":"1","preferredName":"Metachronous Malignant Neoplasm","longName":"3357337","preferredDefinition":"A malignant tumor that arises at a site separate from another, primary malignant tumor in the same anatomic system.  It is not clear if metachronous malignant neoplasms represent new primary tumors or metastatic disease.  Examples include metachronous osteosarcoma of the bones that develops in patients with known primary bone osteosarcoma, and metachronous Wilms' tumor that affects the opposite kidney in patients with a history of Wilms' tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metachronous Malignant Neoplasm","conceptCode":"C38156","definition":"A malignant tumor that arises at a site separate from another, primary malignant tumor in the same anatomic system.  It is not clear if metachronous malignant neoplasms represent new primary tumors or metastatic disease.  Examples include metachronous osteosarcoma of the bones that develops in patients with known primary bone osteosarcoma, and metachronous Wilms' tumor that affects the opposite kidney in patients with a history of Wilms' tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-E9A5-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-18","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D2999F-E9BE-5972-E040-BB89AD430B3F","beginDate":"2012-01-18","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"Unevaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"2570773","version":"1","preferredName":"Unevaluable","longName":"2570773","preferredDefinition":"Unevaluable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E182-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2681BCFF-D52C-5BA8-E050-BB89AD434904","beginDate":"2015-12-09","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-09","modifiedBy":"ONEDATA","dateModified":"2015-12-09","deletedIndicator":"No"},{"value":"Treatment Failure (TF)","valueDescription":"Treatment Failure (TF)","ValueMeaning":{"publicId":"4537076","version":"1","preferredName":"Treatment Failure (TF)","longName":"4537076","preferredDefinition":"Treatment Failure (TF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0579DCCC-0903-3DC2-E050-BB89AD433414","latestVersionIndicator":"Yes","beginDate":"2014-10-15","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8BAF-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"RELAPSE","ValueMeaning":{"publicId":"2562196","version":"1","preferredName":"RELAPSE","longName":"2562196","preferredDefinition":"RELAPSE","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relapse","conceptCode":"C18265","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C001-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-01","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-08-01","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8B9B-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"Partial Response (PR)","valueDescription":"partial response (PR)","ValueMeaning":{"publicId":"2626315","version":"1","preferredName":"partial response (PR)","longName":"2626315","preferredDefinition":"partial response (PR) -- 50% decrease in peripheral blood lymphocyte count from pretreatment value; at least 50% reduction in lymphodenopathy if present pretreatment; at least 50% reduction in level and spleen size if enlarged pretreatment; one or mor of the following: 1) neutrophils at least 1.5 x 10^9/L or 50% improvement over baseline 2) platelets > 100 x 10^9/L or 50% improvement over baseline 3) hemoglobin > 11.0 g/dL or 50% improvement over baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DEBFF43-11A5-2A55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-12","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8BBA-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"Complete Remission with Incomplete Blood Count Recovery (CRi)","valueDescription":"Complete Remission with Incomplete Blood Count Recovery (CRi)","ValueMeaning":{"publicId":"5072631","version":"1","preferredName":"Complete Remission with Incomplete Blood Count Recovery (CRi)","longName":"5072631","preferredDefinition":"Complete Remission with Incomplete Blood Count Recovery (CRi)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2607FC79-8BC5-1527-E050-BB89AD430F6E","latestVersionIndicator":"Yes","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","changeDescription":null,"administrativeNotes":"2023.9.6 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8BDE-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"CR With Partial Recovery of Platelet Count (CRp)","valueDescription":"CR With Partial Recovery of Platelet Count (CRp)","ValueMeaning":{"publicId":"5072632","version":"1","preferredName":"CR With Partial Recovery of Platelet Count (CRp)","longName":"5072632","preferredDefinition":"CR With Partial Recovery of Platelet Count (CRp)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2607FC79-8BE8-1527-E050-BB89AD430F6E","latestVersionIndicator":"Yes","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","changeDescription":null,"administrativeNotes":"2023.9.6 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8C01-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"Complete Remission (CR)","valueDescription":"Complete remission (CR)","ValueMeaning":{"publicId":"4602874","version":"1","preferredName":"Complete remission (CR)","longName":"4602874","preferredDefinition":"A treatment response where all of the following criteria are met for at least four weeks: < 5% blasts in the bone marrow, normal maturation of all cellular components in the bone marrow (myeloid, erythroid, and megakaryocytic lineages), no blasts with Auer rods,  no extramedullary disease (e.g., central nervous system or soft tissue involvement),  ANC of > 1,000/μL, Platelets >= 100,000/ μL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"084C9CCC-B429-E3F0-E050-BB89AD43552C","latestVersionIndicator":"Yes","beginDate":"2014-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2607FC79-8C15-1527-E050-BB89AD430F6E","beginDate":"2015-12-03","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","deletedIndicator":"No"},{"value":"No Response","valueDescription":"No Response","ValueMeaning":{"publicId":"5654573","version":"1","preferredName":"No Response","longName":"5654573","preferredDefinition":"No apparent change or worsening in tumor staging classification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Response","conceptCode":"C123600","definition":"No apparent change or worsening in lesion staging classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47E126E3-C3C0-533A-E053-F662850A36AA","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"47E126E3-C3D9-533A-E053-F662850A36AA","beginDate":"2017-02-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"78450D27-6D01-7B22-E053-F662850A866D","beginDate":"2018-10-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-10-15","modifiedBy":"ONEDATA","dateModified":"2018-10-15","deletedIndicator":"No"},{"value":"Morphologic Leukemia-Free State (MLFS)","valueDescription":"Morphologic Leukemia - Free State","ValueMeaning":{"publicId":"2581112","version":"1","preferredName":"Morphologic Leukemia - Free State","longName":"2581112","preferredDefinition":"The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Morphologic Leukemia-Free State","conceptCode":"C123597","definition":"The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09E5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-02","modifiedBy":"COOPERM","dateModified":"2018-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A135B3F6-349C-257B-E053-F662850AA342","beginDate":"2020-03-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-03-19","modifiedBy":"ONEDATA","dateModified":"2020-03-19","deletedIndicator":"No"},{"value":"Aplasia","valueDescription":"Agenesis","ValueMeaning":{"publicId":"7640819","version":"1","preferredName":"Agenesis","longName":"7640819v1.00","preferredDefinition":"A congenital abnormality resulting in the absence of an anatomical structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agenesis","conceptCode":"C120864","definition":"A congenital abnormality resulting in the absence of an anatomical structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0AB081F-E7AD-58AD-E053-4EBD850A10B7","latestVersionIndicator":"Yes","beginDate":"2021-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-04-23","modifiedBy":"GDEEN","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0AB081F-E7C6-58AD-E053-4EBD850A10B7","beginDate":"2021-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-04-23","modifiedBy":"ONEDATA","dateModified":"2021-04-23","deletedIndicator":"No"},{"value":"Relapse/Refractory Disease","valueDescription":"Relapse/Refractory Disease","ValueMeaning":{"publicId":"7652586","version":"1","preferredName":"Relapse/Refractory Disease","longName":"7652586","preferredDefinition":"Relapse/Refractory Disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BE5F26-39F5-718B-E053-4EBD850A8B12","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BE5F26-3A0E-718B-E053-4EBD850A8B12","beginDate":"2021-05-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","deletedIndicator":"No"},{"value":"MRD Negative","valueDescription":"Minimal Residual Disease Negative Finding","ValueMeaning":{"publicId":"8083085","version":"1","preferredName":"Minimal Residual Disease Negative Finding","longName":"8083085","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA317660-BC8C-7546-E053-4EBD850A1E8B","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA317660-BCA5-7546-E053-4EBD850A1E8B","beginDate":"2022-03-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"MRD Positive","valueDescription":"Minimal Residual Disease Positive Finding","ValueMeaning":{"publicId":"6299956","version":"1","preferredName":"Minimal Residual Disease Positive Finding","longName":"6299956","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CDF575C-6A3A-5EA2-E053-F662850A9813","latestVersionIndicator":"Yes","beginDate":"2018-05-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-05-23","modifiedBy":"ONEDATA","dateModified":"2018-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA317660-BCB9-7546-E053-4EBD850A1E8B","beginDate":"2022-03-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"},{"value":"PET2 negative (RER)","valueDescription":null,"ValueMeaning":{"publicId":"13313062","version":"1","preferredName":"PET2 negative (RER)","longName":"13313062v1.00","preferredDefinition":"PET2 negative (RER)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F89627D1-8C6B-334E-E053-731AD00AFF48","latestVersionIndicator":"Yes","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F89627D1-8C6E-334E-E053-731AD00AFF48","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","deletedIndicator":"No"},{"value":"PET2 positive (SER)","valueDescription":null,"ValueMeaning":{"publicId":"13313063","version":"1","preferredName":"PET2 positive (SER)","longName":"13313063v1.00","preferredDefinition":"PET2 positive (SER)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F89627D1-8C6C-334E-E053-731AD00AFF48","latestVersionIndicator":"Yes","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F89627D1-8C6F-334E-E053-731AD00AFF48","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":null,"ValueMeaning":{"publicId":"5612326","version":"1","preferredName":"Indeterminate","longName":"5612326","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533FADE-5652-7B40-E053-F662850A3056","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F89627D1-8C70-334E-E053-731AD00AFF48","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","deletedIndicator":"No"},{"value":"Progressive Disease / Relapse","valueDescription":null,"ValueMeaning":{"publicId":"13313064","version":"1","preferredName":"Progressive Disease Or Recurrent Neoplasm","longName":"13313064v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The reemergence of a neoplasm after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Neoplasm","conceptCode":"C4798","definition":"The reemergence of a neoplasm after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F89627D1-8C6D-334E-E053-731AD00AFF48","latestVersionIndicator":"Yes","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F89627D1-8C71-334E-E053-731AD00AFF48","beginDate":"2023-04-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","deletedIndicator":"No"},{"value":"Refractory Disease","valueDescription":null,"ValueMeaning":{"publicId":"4571271","version":"1","preferredName":"Refractory Disease","longName":"4571271","preferredDefinition":"A disease that resists treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Refractory Disease","conceptCode":"C39752","definition":"A disease that resists treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06FECA4E-7E2B-9714-E050-BB89AD432ED0","latestVersionIndicator":"Yes","beginDate":"2014-11-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-11-03","modifiedBy":"KUMMEROA","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04B19C5F-C15E-72D2-E063-731AD00A8DEB","beginDate":"2023-09-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5B3C63F-52C3-15D4-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","changeDescription":null,"administrativeNotes":"2023.9.6 PV added per ticket request CADSR0002816. ak 2023.4.5 PVs added per ticket request CADSR0002265. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"},{"publicId":"2811962","version":"1","longName":"Response","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"3298577","version":"1","longName":"Hepatobiliary","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"10000342","version":"1","longName":"Follow-Up","context":"AMC"}]}],"AlternateNames":[{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"OVERAL_LES_RESP_STAT","type":"USED_BY","context":"CTEP"},{"name":"OVERAL_LES_RESP_STAT","type":"USED_BY","context":"AECC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"OVRLRESP_RSORRES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Overall response","type":"Preferred Question Text","description":"Overall response","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Overall response at this assessment","url":null,"context":"CTEP"},{"name":"COG_CRF_Text_1","type":"Alternate Question Text","description":"Patient's overall response","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Overall response for the index lesions since baseline","url":null,"context":"CTEP"},{"name":"AECC TEXT 1","type":"Alternate Question Text","description":"Target response at this assessment","url":null,"context":"AECC"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Disease response:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Target lesion overall response","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"What was the patient's overall response?","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 4","type":"Alternate Question Text","description":"Did patient have a complete response?","url":null,"context":"COG"},{"name":"COG CRF TEXT 5","type":"Alternate Question Text","description":"Overall response:","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Overall response assessment:","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Response assessment:","url":null,"context":"COG"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Pathologic response","url":null,"context":"Alliance"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Pathologic evidence of response","url":null,"context":"Alliance"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Best disease response","url":null,"context":"Alliance"},{"name":"CRF Text5","type":"Alternate Question Text","description":"what was the response to non-protocol therapy","url":null,"context":"Alliance"},{"name":"COG CRF TEXT 8","type":"Alternate Question Text","description":"What is the disease status at the end of this cycle?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Current Status of Disease:","url":null,"context":"COG"},{"name":"AMC Question Text","type":"Alternate Question Text","description":"Response assessment consensus","url":null,"context":"AMC"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5B3E07D-85D7-16BD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"MAESKEB","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}